Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI040102-01
Application #
2004852
Study Section
Special Emphasis Panel (ZRG1-NLS-3 (01))
Project Start
1996-09-15
Project End
1999-08-31
Budget Start
1996-09-15
Budget End
1997-08-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Washington
Department
Pediatrics
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Perez-Melgosa, M; Ochs, H D; Linsley, P S et al. (2001) Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine. Eur J Immunol 31:2373-81
Duplantier, J E; Seyama, K; Day, N K et al. (2001) Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome. Clin Immunol 98:313-8
Barry, S C; Seppen, J; Ramesh, N et al. (2000) Lentiviral and murine retroviral transduction of T cells for expression of human CD40 ligand. Hum Gene Ther 11:323-32
Cunningham, C K; Bonville, C A; Ochs, H D et al. (1999) Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr 134:584-8
Seyama, K; Osborne, W R; Ochs, H D (1999) CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand. J Biol Chem 274:11310-20
Seyama, K; Nonoyama, S; Gangsaas, I et al. (1998) Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92:2421-34
Seyama, K; Kobayashi, R; Hasle, H et al. (1998) Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis 178:318-24